Vladimir А. Gushchin

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Epidemiological characteristics of HIV infection in multidisciplinary hospitals of a large metropolis (Moscow)2026
• Circular mRNA against CleanCap linear mRNA vectors: comprehensive comparison, expression, active and passive immunization2026
• Search for effective bacteriolytic enzymes and their combinations for the treatment of polymicrobial biofilm-associated infections2026
• Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents2026
• Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain2026
• Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia2021
• Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants2021 · аннотациясвернуть

  Since the beginning of the 2021 year, all the main six vaccines against COVID-19 have been used in mass vaccination companies around the world. Virus neutralization and epidemiological efficacy drop obtained for several…

• Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation2021 · аннотациясвернуть

  BACKGROUND: First vaccines for prevention of Coronavirus disease 2019 (COVID-19) are becoming available but there is a huge and unmet need for specific forms of treatment. In this study we aimed to evaluate the…